Incomplete financial disclosure in a study of cell-free hemoglobin-based blood substitutes and risks of myocardial infarction and death

JAMA

Volumn 300, Issue 11, 2008, Pages 1300-

  Natanson, Charles ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE;

CLINICAL RESEARCH; DEONTOLOGY; FUNDING; INTERPERSONAL COMMUNICATION; LETTER; MEDICAL ETHICS; PRIORITY JOURNAL; RESEARCH ETHICS;

EID: 51949098646     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.300.11.1300-a     Document Type: Letter

References (1)

1. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA. 2008;299(19):2304-2312.